We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NDAQ:NASDAQNasdaq, Inc. Analysis

Data as of 2026-05-23 - not real-time

$91.01

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nasdaq, Inc. (NDAQ) is trading at $91.01, just above its 20‑day SMA of 90.49 and its 200‑day SMA of 90.26, but still below the recent resistance of $93.63, indicating a modest upside cushion. The RSI sits at 55.9, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, hinting at short‑term pressure. Volume trends are decreasing, and the 30‑day volatility is elevated at 20.6%, adding to the near‑term uncertainty. Valuation metrics are stretched: the trailing P/E of 27.4 far exceeds the industry average of 16.8, and the DCF‑derived fair value of $47.65 is less than half the current price, pointing to an overvalued market perception. Fundamentally, the company delivers strong revenue growth of 13.7% and impressive operating margins of 48%, with a solid ROE of 16% and free cash flow of $1.56 B. The dividend yield of 1.23% is backed by a modest payout ratio of 32%, supporting sustainability. Debt levels are high (debt‑to‑equity 79%), but cash balances of $531 M and robust cash flow mitigate immediate concerns. Recent index‑rebalancing news—adding Lumentum and SanDisk to the Nasdaq‑100—underscores NDAQ’s role in market infrastructure and may enhance trading volumes. Overall, the stock appears overvalued in the short term, but its strong fundamentals and dividend support a neutral‑to‑bullish stance over longer horizons.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and signal line
  • Decreasing volume trend
  • Current price significantly above DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong revenue and margin expansion
  • Sustainable dividend yield
  • Index‑rebalancing news boosting market visibility

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust free cash flow and low beta
  • Diversified fintech and market services platform
  • Long‑term tailwinds in data and regulatory technology

Key Metrics & Analysis

Financial Health

Revenue Growth13.70%
Profit Margin35.28%
P/E Ratio27.4
ROE16.20%
ROA5.55%
Debt/Equity79.06
P/B Ratio4.3
Op. Cash Flow$2.3B
Free Cash Flow$1.6B
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI55.9
Support$87.32
Resistance$93.63
MA 20$90.49
MA 50$87.86
MA 200$90.26
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$47.65
Target Price$106.47
Upside/Downside16.98%
GradeOvervalued
TypeGrowth
Dividend Yield1.23%

Risk Assessment

Beta0.74
Volatility20.63%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.